| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|---------------------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | Teladoc. HEALTH | | 9 4Q-21 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitat ...

Teladoc Health Inc. (NYSE:TDOC) Q4 2021 Results Conference Call February 22, 2022 4:30 PM ET Company Participants Patrick Feeley - VP, IR Jason Gorevic - CEO Mala Murthy - CFO Conference Call Participants Charles Rhyee - Cowen Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Jailendra Singh - Credit Suisse Jessica Tassan - Piper Sandler Lisa Gill - JPMorgan Dev Weerasuriya - Berenberg Richard Close - Canaccord Genuity Ryan MacDonald - Needham Ryan Daniels - William Blair Sean Dodge - ...

| --- | --- | --- | |-----------------------------------|----------------------------|-------| | | | | | Teladoc.. HEALTH | 00000000 | | | J.P. Morgan Healthcare Conference | 00000000 00000000 00000000 | | | Jason Gorevic, CEO January 2022 | 00000000 00000000 OOOOOOOO | | This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) 2 Manhattanville Road, Suite 203 P ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|---------------|-------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Teladoc. | | | 9 3Q-21 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without ...

Teladoc Health, Inc. (NYSE:TDOC) Q3 2021 Earnings Conference Call October 27, 2021 4:30 PM ET Company Participants Patrick Feeley – Head of Investor Relations Jason Gorevic – Chief Executive Officer Mala Murthy – Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan Sean Wieland – Piper Sandler Jailendra Singh – Credit Suisse Stephanie Davis – SVB Leerink Richard Close – Canaccord Ryan Daniels – William Blair Gwen – Cowen Sean Dodge – RBC Capital Markets Daniel Grasslight – Citigroup Geo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) (Registrant's telephone number includin ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|---------------|-------|---------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | Teladoc. | | 9 2Q-21 Quarterly Results | | | | Safe Harbor This presentation contains, and our officers may make, "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without ...

Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 04-3705970 (State of incorpor ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2020 8i or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37477 TELADOC HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 04-3705970 (State of incorporation) (I ...